当社グループは 3,000 以上の世界的なカンファレンスシリーズ 米国、ヨーロッパ、世界中で毎年イベントが開催されます。 1,000 のより科学的な学会からの支援を受けたアジア および 700 以上の オープン アクセスを発行ジャーナルには 50,000 人以上の著名人が掲載されており、科学者が編集委員として名高い
。オープンアクセスジャーナルはより多くの読者と引用を獲得
700 ジャーナル と 15,000,000 人の読者 各ジャーナルは 25,000 人以上の読者を獲得
Thomas Ciachel
Dextran is extensively exploited in medical products and as a element of medicine- delivering nanoparticles( NPs).Then, we tested whether dextran can serve as the main substrate of NPs and form a stable backbone. We tested dextrans with several molecular millions under several conflation conditions to optimize NP stability [1]. The analysis of the attained nanoparticles showed that dextran NPs that were synthesized from 70 kDa dextran with a 5 degree of oxidation of the polysaccharide chain and 50 negotiation with dodecylamine formed a NP backbone composed of modified dextran subunits, the mean periphery of which in an waterless terrain was around 100 nm. Dextran NPs could be stored in a dry state and reassembled in water. also, we set up that different chemical halves(e.g., medicines similar as doxorubicin) can be attached to the dextran NPs via a pH-dependent bond that allows release of the medicine with lowering pH. We conclude that dextran NPs are a promising nano medicine carrier [2].